Researchers found that sargramostim decreased UCH-L1 and total tau levels in mild-to-moderate Alzheimer’s patients. MMSE ...

With a pivotal trial readout for Cognito’s Spectris due later this year, the company anticipates launching the Alzheimer’s ...

A recent study shows that combining magnetic brain scans with computer models can safely measure how dementia medications ...

Dr Ray O’Connor takes a look at the latest clinical studies on dementia, including its diagnosis and management ...

Lower eGFR and higher urinary protein-to-creatinine ratio were associated with greater risks for cognitive impairment across ...

A person’s combined physical and mental strength can predict their risk of developing memory problems later in life. New ...

Being in a more advanced stage of chronic kidney disease (CKD) comes with an increased risk of cognitive impairment among patients with CKD, according to a February study published in the JAMA Network ...

Middle-aged adults should be tested for a gene that could be responsible for more than 90 percent of Alzheimer's cases, a new ...

A single intravenous ketamine infusion was safe and well-tolerated in older adults with mild cognitive impairment (MCI) and depression (MCI-D), with no serious adverse events (AEs) reported, a small ...

Advanced proteomics and AI reveal blood protein changes, offering insights into early Alzheimer's detection and ...